Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radioguided Occult Lesion Localization (ROLL) is Superior a to the Wire-Guided Lesion Localization (WGLL)? Randomized Controlled Clinical Trial

NCT02869230 is registered in ClinicalTrials.gov with Instituto Nacional de Cancerologia, Columbia as lead sponsor.

NCT NCT02869230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02869230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radioguided Occult Lesion Localization (ROLL) is Superior a to the Wire-Guided Lesion Localization (WGLL)? Randomized Controlled Clinical Trial
Lead sponsor
Instituto Nacional de Cancerologia, Columbia
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2006
Completion date
May 31, 2013
Enrollment
129 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer